Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2008, Vol. 111, No. 3, pp. 1067-1077.
Prepublished online as a Blood First Edition Paper on October 30, 2007; DOI 10.1182/blood-2007-07-098764.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-07-098764v1
111/3/1067    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van de Loosdrecht, A. A
Right arrow Articles by Ossenkoppele, G. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van de Loosdrecht, A. A
Right arrow Articles by Ossenkoppele, G. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 2, 2007
Accepted October 10, 2007

Identification of distinct prognostic subgroups in low and intermediate-1 risk myelodysplastic syndromes by flow cytometry

Arjan A van de Loosdrecht*, Theresia M Westers, August H Westra, Angelika M Drager, Vincent HJ van der Velden, and Gert J Ossenkoppele

Department of Hematology, VU University Medical Center, VU-Institute for Cancer & Immunology, Amsterdam, Netherlands
Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands

* Corresponding author; email: a.vandeloosdrecht{at}vumc.nl.

The WHO classification contributes to refined classification and prognostication of myelodysplastic syndromes (MDS). Flow cytometry might add significantly to diagnostic and prognostic criteria. Our analysis of bone marrow samples from 50 MDS patients showed aberrant expression of differentiation antigens in the myelomonocytic lineage. This also accounted for RA±RS indicating multilineage dysplasia. Aberrancies in granulopoiesis or monocytopoiesis were observed in 92% of the cases and monocytopenia in 40%. In 38% of cases, CD34+ myeloid blasts expressed CD5, CD7 or CD56. Flow cytometry data were translated into a numerical MDS flow-score. Flow-scores increased significantly from RA±RS, RCMD±RS up to RAEB-1 and RAEB-2. No significant differences were observed between WHO-cytogenetic subgroups. Flow-scores were highly heterogeneous within IPSS subgroups. Patients in progression to advanced MDS or acute myeloid leukemia had a significantly higher flow-score compared to non-transfusion-dependent patients. In 60% of patients with transfusion-dependency or progressive disease, myeloid blasts expressed CD7 or CD56 in contrast to only 9% of non-transfusion-dependent patients. Moreover, all pure RA±RS patients with aberrant myeloid blasts showed an adverse clinical course. In conclusion, flow cytometry in MDS identified aberrancies in the myelomonocytic lineage not otherwise determined by cytomorphology. Additionally, flow cytometry identified patients at risk for transfusion dependency and/or progressive disease independent of known risk groups, which might have impact on treatment decisions and prognostic scoring system in the near future.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
A. Tefferi and J. W. Vardiman
Myelodysplastic Syndromes
N. Engl. J. Med., November 5, 2009; 361(19): 1872 - 1885.
[Full Text] [PDF]


Home page
BloodHome page
M. L. Chen, T. D. Logan, M. L. Hochberg, S. G. Shelat, X. Yu, G. E. Wilding, W. Tan, G. C. Kujoth, T. A. Prolla, M. A. Selak, et al.
Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction
Blood, November 5, 2009; 114(19): 4045 - 4053.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. Cazzola
Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome
Haematologica, August 1, 2009; 94(8): 1041 - 1043.
[Full Text] [PDF]


Home page
haematolHome page
N. Goardon, E. Nikolousis, A. Sternberg, W.-K. Chu, C. Craddock, P. Richardson, R. Benson, M. Drayson, G. Standen, P. Vyas, et al.
Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes
Haematologica, August 1, 2009; 94(8): 1160 - 1163.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. A. van de Loosdrecht, C. Alhan, M. C. Bene, M. G. Della Porta, A. M. Drager, J. Feuillard, P. Font, U. Germing, D. Haase, C. H. Homburg, et al.
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
Haematologica, August 1, 2009; 94(8): 1124 - 1134.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
K. Ogata, M. G. Della Porta, L. Malcovati, C. Picone, N. Yokose, A. Matsuda, T. Yamashita, H. Tamura, J. Tsukada, and K. Dan
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study
Haematologica, August 1, 2009; 94(8): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. E.D. Chamuleau, T. M. Westers, L. van Dreunen, J. Groenland, A. Zevenbergen, C. M. Eeltink, G. J. Ossenkoppele, and A. A. van de Loosdrecht
Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome
Haematologica, April 1, 2009; 94(4): 496 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
R. S. Komrokji and J. M. Bennett
What Is "WHO"?: Myelodysplastic Syndrome Classification and Prognosis
ASCO Educational Book, January 1, 2009; 2009(1): 413 - 419.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. L. Scott, D. A. Wells, M. R. Loken, D. Myerson, W. M. Leisenring, and H. J. Deeg
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome
Blood, October 1, 2008; 112(7): 2681 - 2686.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020